Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-11-29-Speech-3-219"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20061129.18.3-219"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"The Seventh Framework Research Programme is supposed to be designed as a tool at the service of an integral research policy that is simplified, is more accessible to SMEs and strengthens the links between research and industry in particular. It almost lives up to that aim.
The fact is that concerns and questions remain, especially with regard to the participation of SMEs, where the access costs for participants and access to the risk-sharing finance facility still pose problems, with regard to coherence and the absence of confusion with other Community policies, with regard to the dissemination of knowledge, where quality and respect for intellectual property are issues, and with regard to the role of Member States in the governance of the programme. The seven-year duration of the programme also seems to be ill-suited to the pursuit of research goals, which are liable to change rapidly in spite of prescribed phases and evaluations.
We also regret that research on embryonic stem cells has not been banned and that Parliament, like the Council and the Commission, has confined itself to mere definitions and restrictions in this domain.
It remains no less true, however, that research, if it is the subject of a policy based on the pursuit of excellence, is one of the few areas in which the European Union can truly deliver better results than national activities could achieve."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples